Add BrightSurf on Google Email

Research shows soil temperature modulated millet agriculture in Neolithic East Asia

Researchers found that mid-Holocene soil cooling reduced thermally suitable zones for millet cultivation, contributing to a southward displacement of farming. Soil temperatures recovered after around 6,000 years ago, facilitating millet expansion and late Neolithic development.

SourceChinese Academy of Sciences Headquarters·JournalProceedings of the National Academy of Sciences·TypeMeta-analysis·DateMay 7, 2026

Scientists find blood-based biomarkers for inflammatory breast cancer

Researchers at the University of Texas MD Anderson Cancer Center have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes. The study used an improved method of RNA sequencing, called TGIRT sequencing, which allowed for a more comprehensive overview of all RNA types and amou...

Blood tests taken years earlier linked to pregnancy risk

A new study from Karolinska Institutet found that small abnormalities in blood sugar, lipids, and inflammation years before pregnancy are associated with an increased risk of high blood pressure during pregnancy and pre-eclampsia. The findings may contribute to earlier risk assessment and preventive measures.

SourceKarolinska Institutet·JournalJAMA Network Open·TypeObservational study·DateApr 30, 2026

Not all organs age alike: AI unveils the molecular impact of menopause across the female body

A new study reveals that menopause causes profound and uneven transformations across the female reproductive system, rather than a uniform decline. The research identified molecular signals associated with aging detectable in blood, allowing for non-invasive monitoring and earlier detection of risks.

SourceBarcelona Supercomputing Center·JournalNature Aging·TypeData/statistical analysis·DateApr 29, 2026

New study finds blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes

Researchers found that a blood test for the biomarker pTau217 can predict the progression of Alzheimer's disease in cognitively healthy adults, detecting early signals years before symptoms appear. The study's findings may help push back the clock to enable simpler and earlier disease prediction.

SourceMass General Brigham·JournalNature Communications·TypeObservational study·DateApr 14, 2026

Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome

A new blood-based biomarker has been discovered to help identify individuals at higher risk of developing cancer in people with Lynch Syndrome. The biomarker uses immune signatures detected in blood samples to provide unique characteristics that can detect cancer risk, allowing for early detection and personalized surveillance.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Communications·DateApr 6, 2026

Markers of lymphoma cancer relapse identified

A new study from the University of Missouri identified over 10 genetic or molecular markers that predict follicular lymphoma relapse early, allowing for targeted surveillance testing. This could improve patient outcomes, reduce unnecessary imaging tests, and lower healthcare costs.

SourceUniversity of Missouri-Columbia·JournalAmerican Journal of Clinical Oncology·TypeData/statistical analysis·DateMar 31, 2026

New biomarker for immunoglobulin a nephropathy identified

Researchers have discovered a new biomarker for immunoglobulin A (IgA) nephropathy, which is an autoimmune disease that can lead to kidney failure. Complement pathway proteins, including CFHR1, were found to be overexpressed in patients with IgA nephropathy, suggesting a potential treatment target and diagnostic marker.

SourceFujita Health University·JournalScientific Reports·TypeExperimental study·DateMar 30, 2026

Simple tumor biomarker test predicts which stomach cancer patients will respond to immunotherapy

Researchers have discovered a tumor biomarker that can predict which gastric cancer patients will benefit from immunotherapy before surgery. The biomarker, tsMHC-II expression, showed strong correlation with treatment response and was easily assessable using standard immunohistochemistry techniques.

SourceScience China Press·JournalScience Bulletin·TypeRandomized controlled/clinical trial·DateMar 27, 2026

IGFBP1 shows promise as a non-invasive biomarker for monitoring disease activity in elderly IBD patients

A recent study found that IGFBP1 levels are significantly higher in elderly IBD patients and negatively correlated with inflammation-related markers. Elevated IGFBP1 levels were associated with lower clinical, endoscopic, and histological disease activity, suggesting a promising non-invasive tool for managing elderly IBD patients.

SourceFAR Publishing Limited·JournalCurrent Molecular Pharmacology·DateMar 24, 2026

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

Researchers at Lund University have developed a new blood marker that significantly improves the accuracy of Alzheimer's diagnosis. The study found that combining two biomarkers, p-tau217 and eMTBR-tau243, can identify people with established Alzheimer's disease with an accuracy rate of around 80%. This breakthrough reduces false posit...

SourceLund University·JournalThe Lancet Neurology·TypeObservational study·DateMar 23, 2026

Cerebrovascular lesions in down syndrome do not follow a linear course

A longitudinal study on individuals with Down syndrome reveals that cerebrovascular lesions do not follow a linear course, fluctuating and even decreasing over time. The analysis shows significant variability in the evolution of these lesions, particularly in regions already affected by Alzheimer's disease.

SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalAlzheimer’s & Dementia·TypeObservational study·DateMar 19, 2026

How old are we really?

Researchers develop method using biomarkers to calculate individual biological age, finding significant differences in age-related changes between men and women. The study also identifies clinically relevant biomarkers linked to biological age, opening up new opportunities for preventive medicine.

SourceUniversity of Konstanz·JournalAging Cell·DateMar 19, 2026

Tumor-informed liquid biopsy suggests structural-variant ddPCR can monitor high-grade serous ovarian cancer

A novel method for monitoring on-treatment disease burden in high-grade serous ovarian cancer uses tumor-informed breakpoints-spanning ddPCR, detecting superior sensitivity and specificity compared to real-time PCR. The approach may enable sensitive and specific detection of minimal residual disease and early relapse detection.

SourceImpact Journals LLC·JournalOncoscience·TypeNews article·DateMar 19, 2026

A comprehensive review charts how psychiatry could finally diagnose what it actually treats

Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateMar 10, 2026

Chinese Neurosurgical Journal study develops radiomics model to predict secondary decompressive craniectomy

A Chinese Neurosurgical Journal study developed a radiomics-based machine learning model to identify high-risk patients with traumatic brain injury who require emergency decompressive surgery. The model accurately distinguished patients who later required secondary surgery, suggesting its potential to complement clinical judgment.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeObservational study·DateMar 10, 2026

New PET imaging study reveals how ketamine relieves treatment-resistant depression

A new PET imaging study reveals that ketamine relieves treatment-resistant depression by altering AMPAR in brain regions, providing potential biomarker for personalized treatment. The study found that ketamine increased AMPAR density in several cortical regions and decreased it in reward-related areas, strongly correlating with reducti...

SourceYCU Advanced Medical Research Center·JournalMolecular Psychiatry·TypeImaging analysis·DateMar 6, 2026